Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis.

Yang, S J; Hwang, S Y; Choi, H Y; Yoo, H J; Seo, J A; Kim, S G; Kim, N H; Baik, S H; Choi, D S; Choi, K M

Yang, S J; Hwang, S Y; Choi, H Y; Yoo, H J; Seo, J A; Kim, S G; Kim, N H; Baik, S H; Choi, D S; Choi, K M.

Affiliation

Yang SJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Seoul 152-050, Korea.

J Clin Endocrinol Metab ; 96(8): E1325-9, 2011 Aug.

Article in En | MEDLINE | ID: mdl-21677040

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Insulin Resistance / Carotid Artery Diseases / Diabetes Mellitus, Type 2 / Selenoprotein P / Inflammation Type of study: Diagnostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2011 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google